ARCHIVES

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

Scientists Lose Credibility When “Fire Alarm” Pulled Too Early, ACS’s Brawley Says.

August 1, 2008

Data-Dredging? Don’t Try It, FDA Says.

May 11, 2007

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

ACS Courage award Goes To Polhill, Former Beirut Hostage

March 29, 1991

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

September 20, 2013